Sprint Bioscience AB announced that it has received funding on October 8, 2012. The round included participation from existing investors First Venture Sweden AB (publ) and ALMI Invest Stockholm, a fund managed by Almi Invest AB.

On October 8, 2012, Sprint Bioscience AB closed the transaction.